311 related articles for article (PubMed ID: 30906411)
21. Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial.
Tong X; Xu J; Lian F; Yu X; Zhao Y; Xu L; Zhang M; Zhao X; Shen J; Wu S; Pang X; Tian J; Zhang C; Zhou Q; Wang L; Pang B; Chen F; Peng Z; Wang J; Zhen Z; Fang C; Li M; Chen L; Zhao L
mBio; 2018 May; 9(3):. PubMed ID: 29789365
[TBL] [Abstract][Full Text] [Related]
22. Xiexin Tang ameliorates dyslipidemia in high-fat diet-induced obese rats via elevating gut microbiota-derived short chain fatty acids production and adjusting energy metabolism.
Xiao S; Zhang Z; Chen M; Zou J; Jiang S; Qian D; Duan J
J Ethnopharmacol; 2019 Sep; 241():112032. PubMed ID: 31220598
[TBL] [Abstract][Full Text] [Related]
23. Gut microbiota: a potential target for traditional Chinese medicine intervention in coronary heart disease.
Cheng TY; Li JX; Chen JY; Chen PY; Ma LR; Zhang GL; Yan PY
Chin Med; 2021 Oct; 16(1):108. PubMed ID: 34686199
[TBL] [Abstract][Full Text] [Related]
24. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
25. Gut microbiota modulation with traditional Chinese medicine: A system biology-driven approach.
Yue SJ; Wang WX; Yu JG; Chen YY; Shi XQ; Yan D; Zhou GS; Zhang L; Wang CY; Duan JA; Tang YP
Pharmacol Res; 2019 Oct; 148():104453. PubMed ID: 31541688
[TBL] [Abstract][Full Text] [Related]
26. Single-Anastomosis Duodenal Jejunal Bypass Improve Glucose Metabolism by Regulating Gut Microbiota and Short-Chain Fatty Acids in Goto-Kakisaki Rats.
Yu X; Wu Z; Song Z; Zhang H; Zhan J; Yu H; Huang H; Yang B; Xie L; Dai X; Zhao W; Yu J; Wu L
Front Microbiol; 2020; 11():273. PubMed ID: 32153548
[TBL] [Abstract][Full Text] [Related]
27. Mitochondria as novel mediators linking gut microbiota to atherosclerosis that is ameliorated by herbal medicine: A review.
Li Y; Yang S; Jin X; Li D; Lu J; Wang X; Wu M
Front Pharmacol; 2023; 14():1082817. PubMed ID: 36733506
[TBL] [Abstract][Full Text] [Related]
28. Research progress on Traditional Chinese Medicine syndromes of diabetes mellitus.
Wang J; Ma Q; Li Y; Li P; Wang M; Wang T; Wang C; Wang T; Zhao B
Biomed Pharmacother; 2020 Jan; 121():109565. PubMed ID: 31704615
[TBL] [Abstract][Full Text] [Related]
29. [Compound traditional Chinese medicine in treatment of diabetes].
Wu QH; Li BT; Tu J
Zhongguo Zhong Yao Za Zhi; 2019 Mar; 44(6):1104-1109. PubMed ID: 30989971
[TBL] [Abstract][Full Text] [Related]
30. Intestinal mucosal barrier: a potential target for traditional Chinese medicine in the treatment of cardiovascular diseases.
Liu J; Wei X; Wang T; Zhang M; Gao Y; Cheng Y; Chi L
Front Pharmacol; 2024; 15():1372766. PubMed ID: 38469405
[TBL] [Abstract][Full Text] [Related]
31. [Research advance in metabolism of effective ingredients from traditional Chinese medicines by probiotics].
Dai CE; Li HL; He XP; Zheng FF; Zhu HL; Liu LF; Du W
Zhongguo Zhong Yao Za Zhi; 2018 Jan; 43(1):31-38. PubMed ID: 29552808
[TBL] [Abstract][Full Text] [Related]
32. Cross-Talk between Gut Microbiota and the Heart: A New Target for the Herbal Medicine Treatment of Heart Failure?
Li L; Zhong S; Cheng B; Qiu H; Hu Z
Evid Based Complement Alternat Med; 2020; 2020():9097821. PubMed ID: 32328141
[TBL] [Abstract][Full Text] [Related]
33. Impact of traditional Chinese medicine treatment on chronic unpredictable mild stress-induced depression-like behaviors: intestinal microbiota and gut microbiome function.
Qu W; Liu S; Zhang W; Zhu H; Tao Q; Wang H; Yan H
Food Funct; 2019 Sep; 10(9):5886-5897. PubMed ID: 31464319
[TBL] [Abstract][Full Text] [Related]
34. Microbial Ecosystem in Diabetes Mellitus: Consideration of the Gastrointestinal System.
Yehualashet AS; Yikna BB
Diabetes Metab Syndr Obes; 2021; 14():1841-1854. PubMed ID: 33953584
[TBL] [Abstract][Full Text] [Related]
35. [Interaction of effective ingredients from traditional Chinese medicines with intestinal microbiota].
Zu XP; Lin Z; Xie HS; Yang N; Liu XR; Zhang WD
Zhongguo Zhong Yao Za Zhi; 2016 May; 41(10):1766-1772. PubMed ID: 28895319
[TBL] [Abstract][Full Text] [Related]
36. Effect of natural polyphenols in Chinese herbal medicine on obesity and diabetes: Interactions among gut microbiota, metabolism, and immunity.
Chen K; Gao Z; Ding Q; Tang C; Zhang H; Zhai T; Xie W; Jin Z; Zhao L; Liu W
Front Nutr; 2022; 9():962720. PubMed ID: 36386943
[TBL] [Abstract][Full Text] [Related]
37. [Progress in application of bile acid metabolism in traditional Chinese medicine study].
Ju YH; Yao WF; Zhang L
Zhongguo Zhong Yao Za Zhi; 2020 May; 45(10):2360-2367. PubMed ID: 32495593
[TBL] [Abstract][Full Text] [Related]
38. Active ingredients of traditional Chinese medicine in the treatment of diabetes and diabetic complications.
Zhang TT; Jiang JG
Expert Opin Investig Drugs; 2012 Nov; 21(11):1625-42. PubMed ID: 22862558
[TBL] [Abstract][Full Text] [Related]
39. The Role of Gut Microbiota in the Progression of Parkinson's Disease and the Mechanism of Intervention by Traditional Chinese Medicine.
Huan P; Wang L; He Z; He J
Neuropsychiatr Dis Treat; 2022; 18():1507-1520. PubMed ID: 35923300
[TBL] [Abstract][Full Text] [Related]
40. Gut microbiota, a hidden protagonist of traditional Chinese medicine for acute ischemic stroke.
Gao L; Xia X; Shuai Y; Zhang H; Jin W; Zhang X; Zhang Y
Front Pharmacol; 2023; 14():1164150. PubMed ID: 37124192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
